Hanall Biopharma disclosed Wednesday that its second-quarter consolidated operating profit rose 388.5 percent from a year earlier to 5.598 billion won ($3.82 million).
Revenue for the same period came in at 44.276 billion won, up 8.8 percent on-year, according to preliminary results.
The company swung to a net loss of 19.229 billion won for the quarter.
jiyoon436@heraldcorp.com
